| Molecular Formula | C23H31NO3 |
| Molar Mass | 369.5 |
| Density | 1.22±0.1 g/cm3(Predicted) |
| Melting Point | 216°C |
| Boling Point | 497.9±45.0 °C(Predicted) |
| Specific Rotation(α) | D25 +110° |
| Flash Point | 254.919°C |
| Solubility | DMSO: soluble5mg/mL (clear solution) |
| Vapor Presure | 0mmHg at 25°C |
| Appearance | powder |
| Color | white to beige |
| BRN | 6440219 |
| pKa | 12.21±0.60(Predicted) |
| Storage Condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| Stability | Hygroscopic |
| Refractive Index | 1.611 |
| Physical and Chemical Properties | Melting Point: 216°C |
| In vitro study | Norgestimate is converted to at least two active metabolites: levonorgestrel 3-oxime (deacetylated norgestimate; norelgestromin) and levonorgestrel. |
| Hazard Symbols | Xn - Harmful![]() |
| Risk Codes | R63 - Possible risk of harm to the unborn child R22 - Harmful if swallowed R36/38 - Irritating to eyes and skin. R62 - Possible risk of impaired fertility |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37 - Wear suitable protective clothing and gloves. |
| WGK Germany | 3 |
| RTECS | JF7976000 |
| HS Code | 2937230000 |